Form 4: Intuitive Surgical CFO Jamie Samath Acquires PSUs
Insider Transaction Report
Intuitive Surgical's EVP & CFO, Jamie Samath, reported the acquisition of performance stock units (PSUs) totaling 10,362 shares, with performance criteria achieved.
Summary
- Jamie Samath, Executive Vice President & Chief Financial Officer & Enterprise Technology of INTUITIVE SURGICAL INC (ISRG), reported changes in beneficial ownership.
- The filing details the acquisition of two tranches of Performance Stock Units (PSUs).
- The first tranche consists of 3,180 PSUs initially granted on February 26, 2024.
- The performance criteria for these 3,180 PSUs have been achieved, as determined by the Compensation Committee of the Issuer.
- These 3,180 PSUs are scheduled to vest on February 26, 2027, contingent on continuous service to the Issuer.
- The second tranche consists of 7,182 PSUs initially granted on February 28, 2023.
- The performance criteria for these 7,182 PSUs have also been achieved, as determined by the Compensation Committee of the Issuer.
- These 7,182 PSUs are scheduled to vest on February 28, 2026, contingent on continuous service to the Issuer.
- The total number of PSUs reported as acquired, with performance criteria met, is 10,362.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this filing as moderately positive. The achievement of performance criteria for executive PSUs suggests the company met its internal targets, which is a favorable signal, though it is a routine compensation disclosure.
Positives
- Performance criteria for both tranches of Performance Stock Units (PSUs) have been achieved, indicating the company met specific targets set by the Compensation Committee.
- The vesting of these PSUs aligns the executive's long-term interests with shareholder value, contingent on continued service.
Risks
- Vesting of the PSUs is subject to the Reporting Person's continuous service to the Issuer through each specified vesting date.
Future Outlook
The filing indicates future vesting of Performance Stock Units (PSUs) on February 28, 2026, and February 26, 2027, contingent on the Reporting Person's continuous service to the Issuer.
Industry Context
StockSavvy.ai notes that the grant and vesting of Performance Stock Units (PSUs) with performance hurdles are a common form of executive compensation in the medical device and technology sectors. This practice aims to align the interests of key executives, such as the CFO, with the long-term performance and strategic goals of the company, which is standard for a leader in robotic-assisted surgery like Intuitive Surgical.
Comparison to Industry Standards
- Performance Stock Unit (PSU) grants with multi-year vesting schedules and performance criteria are a standard component of executive compensation packages across large-cap technology and medical device companies, similar to practices at firms like Medtronic, Johnson & Johnson, or Stryker.
- The achievement of performance criteria for these PSUs is a positive indicator, suggesting that internal targets, often tied to financial metrics or operational milestones, have been met, which is a common trigger for PSU vesting in the industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Decision | The Compensation Committee of the Issuer determined that the performance criteria for the reported Performance Stock Units (PSUs) have been achieved. | 01/28/2026 | This demonstrates the Compensation Committee's oversight in evaluating and approving executive compensation based on pre-defined performance metrics, reinforcing governance practices. |
Stakeholder Impact
- Shareholders: The achievement of performance criteria for executive compensation can be viewed positively, as it suggests the company met specific targets, potentially aligning executive incentives with shareholder value creation.
- Employees: The continuous service requirement for vesting reinforces executive retention.
Next Steps
- Vesting of 7,182 PSUs on February 28, 2026, subject to continuous service.
- Vesting of 3,180 PSUs on February 26, 2027, subject to continuous service.
Key Dates
| Date | Description |
|---|---|
| 02/28/2023 | Initial grant date for 7,182 Performance Stock Units (PSUs). |
| 02/26/2024 | Initial grant date for 3,180 Performance Stock Units (PSUs). |
| 01/28/2026 | Date of earliest transaction reported on the Form 4, likely related to the achievement of performance metrics. |
| 02/28/2026 | Vesting date for 7,182 Performance Stock Units (PSUs). |
| 02/26/2027 | Vesting date for 3,180 Performance Stock Units (PSUs). |
| 01/30/2026 | Signature date of the Reporting Person's representative. |
Recommendation
holdThis Form 4 reports the achievement of performance criteria for previously granted executive compensation, which is a standard and expected event. It does not provide new material information that would significantly alter the investment thesis for Intuitive Surgical, hence a 'hold' recommendation is appropriate based solely on this filing.
Keywords
ISRG, Intuitive Surgical, Form 4, Insider Transaction, Performance Stock Units, Executive Compensation, Jamie Samath
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.